How AI Is Aiming at the Bad Math of Drug Development

Robert Marcus
Nov 29, 2021

Related news

Dec 30
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Experts predict massive growth in health tech

Nov 9
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Accenture (ACN) Announces Strategic Investment in Geneyx

Oct 4
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

The Coming Age for Tech x Bio: The “Industrial Bio Complex”

Jan 25
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Instadeep raises $100M for AI decision-making tools

Sep 20
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Jeito extends global reach in oversubscribed $625M venture fund

Dec 30
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Tech analysts share new AI opportunities

Oct 12
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

European Biotech Investors Cap Off Record Year in Fundraising

Sep 21
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Artificial intelligence a key challenge for Germany's next government

Oct 18
,
2021
AI
Cleantech
Healthcare
Investment
Life Science
Press

Gartner survey of CIOs highlights investments in AI, cloud and cybersecurity

Feb 1
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

ALPHA10X Emerges from Stealth With $9.4 Million In Seed Funding

Feb 21
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

Innovative AI-powered Search and Discovery Platform; Interview With Robert Marcus

Mar 29
,
2022
AI
Cleantech
Healthcare
Investment
Life Science
Press

3 Myths About Women Working in Tech, Busted